To assess whether chemotherapy in EPCAM+ and EPCAM− as well as EPCAM−Rhoj-KO tumour cells induces DNA damage and differentially activates the DDR pathways, we investigated the level of phosphorylation of ATM and ATR substrates, two main kinases that activate the DDR after DNA damage22. This evidence concerns the gene EPCAM and neoplasm.